Webinar Overview: Driving Cell Therapy Success with Quality Donor Material
The global market for cell and gene therapies shows no sign of slowing down. As the market continues to grow, thorough quality assurance guidelines for tracking and documenting biological raw material has proven to be extremely critical.
In this webinar, we discuss how sourcing cellular starting material as well as a highly characterized donor network can contribute to maintaining regulatory compliance while advancing your cell or gene therapy program.
View to learn:
- How defining exact donor demographic and characterization specifications for human derived cellular material impacts a large recallable donor pool
- The importance of maintaining consistent donor safety measures and apheresis collection protocols in accordance with regulatory guidelines
- How effective quality assurance enables the application of cellular starting material for downstream development, manufacturing, and clinical use of advanced therapies
Webinar Presenters
Jordan Hunter, PhD
Product Manager
Charles River
Lanu Stoddart, MD
Medical Director
Charles River